Navigation Links
Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicine's 28th Annual Meeting
Date:2/27/2012

to this new mu-opioid analgesic molecule is that it does not rely on a formulation to decrease its abuse liability. With a ten-fold slower entry into the brain as compared to oxycodone, NKTR-181 avoids the rush into the brain associated with euphoria.  Adding to our excitement is the data that shows the peripheral analgesic and anti-hyperalgesic effects of NKTR-181 in multiple pain models. We will seek to capitalize on the properties of this unique molecule as we advance NKTR-181 into Phase 2 development this year."

In a separate presentation of preclinical data at the AAPM Meeting, NKTR-181 resulted in less sedation and abuse liability as compared to oxycodone in multiple animal models across a wide range of doses.  As predicted from its molecular design, NKTR-181 has a reduced rate of entry into the brain in rodents.  This feature contributed to a 30-fold shift in the dose-response for abuse liability and a 10-fold shift in the dose response for sedation relative to oxycodone.

Chronic pain conditions, such as osteoarthritis, back pain and cancer pain, affect at least 126 million adults in the U.S. annually and contribute to over $100 billion a year in lost productivity.(2) 

About the NKTR-181 Phase 1 Multiple Ascending Dose Study

This Phase 1, double-blind, randomized, placebo-controlled, ascending multiple dose study of NKTR-181 was conducted in the U.S. at Lifetree Clinical Research. The study enrolled a total of 60 healthy subjects over an eight-day treatment period.  Four dose cohorts were evaluated with 15 subjects in each dose cohort (100 mg, 200 mg, 300 mg, 400 mg).  Subjects in each cohort received oral twice-daily doses of NKTR-181 (n=12) in aqueous solution or placebo (n=3) following an overnight fast.  Pharmacokinetics were determined through serial blood samples. Serial opioid pharmacodynamic tests included the cold-pressor test (CPT) and a UVB injury model to assess both central
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets
2. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
3. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
4. Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
6. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
7. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
8. Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
10. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
11. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015   Eli Lilly and Company ... ) will host a webcast on June 11 to discuss ... baricitinib in rheumatoid arthritis. Data from these two trials, RA-BEACON and ... Programme for the EULAR Congress 2015 in Rome, ... from 10:00 to11:00 a.m. Eastern Daylight Time. The live audio ...
(Date:5/28/2015)... 28, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in healthcare, life science ... agreement with the fertility technologies expert Genea Biomedx, ... and helping couples create families. With this partnership, ... a global market leader in drugs for Assisted ...
(Date:5/28/2015)... CHICAGO , May 28, 2015  The ... left health plans and employer groups scrambling to ... by a major managed care plan, retail pharmacy ... United Healthcare,s $13.3 billion purchase of Catamaran, Rite ... recent announcement to purchase Omni-Care for $10 billion ...
Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
... a global provider of comprehensive sample management solutions ... logistics and virtual sample intelligence, will host its ... May 2012 in Brussels, Belgium from 16:00 – ... Dr. Graham Hughes, Consultant in Pharmaceutical Development and ...
...  NxStage® Medical, Inc. (Nasdaq: NXTM ), ... announced that former NxStage® System One™ patient Nikolas ... following four successful years of more frequent home ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom ...
Cached Medicine Technology:BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 2Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant 3
(Date:5/28/2015)... Kentucky (PRWEB) May 29, 2015 On Monday, ... its newest location at 160 Frankfort Road in Shelbyville, Kentucky ... oversee all operations as well as treat patients , ... provide a more convenient , local clinic to better serve ... patients first making their experience as trouble-free as possible by ...
(Date:5/28/2015)... 28, 2015 The USC Verdugo Hills Hospital ... management for a decade with a current average healing rate ... USC and Wound Care Advantage to provide in-patient wound care. ... for a drop in the rate of hospital-acquired pressure ulcers ... is a complex undertaking that can frighten patients and caregivers ...
(Date:5/28/2015)... Success Strategies for Biosimilars Approval:, ... Webinar**, June 23, 2015 — 11:00 a.m. – ... June 23, 2015, FDAnews is offering the combined ... attorneys from the international law firm Duane Morris ... A Roadmap to the 351(k) Application Process. , ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 Three years ... new location for his Shore Vascular & Vein Center! ... the circulatory system. It is his mission to provide ... and respect. , Dr. Jeffrey Gosin is Board ... of the University of Pennsylvania and Jefferson Medical College. He ...
(Date:5/28/2015)... Ross A. Clevens, MD, FACS, Brevard’s ... Beard as the new marketing director for Clevens Face ... all marketing and promotional events for the practice. Beard ... developing compelling marketing strategies to achieve targeted results. Prior ... as guest communication manager at the Walt Disney World ...
Breaking Medicine News(10 mins):Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2
... a reservoir of information has done unimaginable wonders to industries ... ‘net’ working is the byword of the present age, with ... it comes as no surprise that the internet is being ... issues pertaining to health. ,While acknowledging that it is ...
... India Wednesday sounded a bird flu alert in all states ... of winter.// ,"We have given clear instruction to ... be in place till February next year," said Upma Chawdhry, ... states - Maharashtra, Gujarat and Madhya Pradesh - where the ...
... the green signal to launch a novel drug for the ... COX-2 inhibitor that seems to have no other side effects ... drugs used clinically for arthritis and of the same class ... as Vioxx and Bextra have reported heart problems in the ...
... Painless vaccines that could simply be stuck like a band-aid ... tested for protection against the flu and travelers’ diarrhea. ... early trials with the funding from the National Institutes of ... not just be painless; it may easily be used by ...
... pleasures beseechingly captures the focus of a man and holds ... away the first impressions indelibly in the recesses of his ... men, heterosexual women, homosexual men and bisexual women in groups ... concealed image of female nude or sexually arousing picture is ...
... spondylosis and badly treated fractures are some of the ... and are often laid up, according to orthopaedic experts ... the world with many delicate and complicated surgeries being ... orthopaedics department at the All India Institute of Medical ...
Cached Medicine News:Health News:If The World Wide Web is Your Self Proclaimed Physician, Trouble Could be Just a Click Away 2Health News:India sounds bird flu alert as migration season begins 2Health News:Skin-patch vaccines may replace injectable ones in future… 2Health News:Naked truths and Basic Instincts 2Health News:Mismanagement of fractures a major concern, say experts 2
This is a 3D transducer for endovaginal imaging in OB/GYN....
Super High Density, 120 field of view, angled handle, multi-frequency, convex endovaginal transducer....
Super High Density, 120 degree field of view, straight handle, multi-frequency, convex endovaginal transducer....
Visualize the prostate in both transverse and longitudinal planes....
Medicine Products: